The development of effective antiviral medications often hinges on the availability of precise and high-quality pharmaceutical intermediates. Among these, 1-β-D-Arabinofuranosyluracil, identified by its CAS number 3083-77-0, plays a pivotal role, particularly as a precursor for adenine arabinoside.

Adenine arabinoside, a potent antiviral agent, requires stringent purity standards in its synthetic pathway, starting with its intermediate. Our company, as a dedicated manufacturer and supplier of 1-β-D-Arabinofuranosyluracil, ensures that this compound meets the necessary specifications for pharmaceutical applications. With an assay of ≥98.0% (HPLC), a loss on drying of ≤0.5%, and very low residue on ignition (≤0.1%) and heavy metal content (≤10ppm), we provide a product that pharmaceutical formulators can trust when they buy critical raw materials.

Understanding the chemical structure and properties is essential for researchers and procurement specialists. 1-β-D-Arabinofuranosyluracil has the molecular formula C9H12N2O6 and a molecular weight of 244.20100. Its physical form as a white to off-white crystalline powder, with a melting point of 220-222°C, makes it stable and manageable for industrial synthesis.

For companies seeking to purchase this essential intermediate, partnering with a reliable supplier in China offers significant advantages, including competitive price and a consistent supply chain. We are committed to facilitating your drug synthesis projects by providing readily available, high-quality 1-β-D-Arabinofuranosyluracil. Our expertise in chemical manufacturing means we can support your needs for both research quantities and bulk orders required for large-scale production.

When considering your options to buy Uracil arabinoside or related nucleoside analogues, prioritizing the quality and reliability of the supplier is key. We stand ready to be your trusted source for CAS 3083-77-0, contributing to the advancement of antiviral therapies through our commitment to excellence in chemical manufacturing.